fda warning bpc-157 compounded peptide I am getting so many messages An FDA advisory committee voted

doi: 10.1177/24705470221076390 207 TanYKaganJC

Molecular and Cellular Endocrinology

5-Amino-1MQ was developed as a selective NNMT inhibitor to help researchers better understand the biological significance of NNMT activity

(8) This potential of the peptide may help improve tissue regeneration and reduce tissue damage, possibly promoting better wound recovery and healing and decreasing the formation of scars in experimental murine models

FDA materials instead discuss GHK-Cu in compounding contexts, including category updates for non-injectable routes and safety concerns for injectable routes [8], 19

Since the blend contains peptides frequently studied in relation to these components, it may be useful in experimental models involving ligaments, cartilage, skin, and tendon tissues